Genmab A GMAB
NASDAQ GMAB
$54.07 -1.73 (-3.10%)
At close: Nov 10, 2026 · 4:00 PM EST

Genmab A (GMAB) Tax Rate (2024 - 2025)

Updated

Genmab A (GMAB) recorded Tax Rate of 20.02% in the year ended Dec 31, 2025, up 5.46 percentage points from 14.56% a year earlier.

Analysis

Genmab A (GMAB) Tax Rate (2024 - 2025) Analysis & Trends

  • Per Business Quant data, GMAB's Tax Rate was 14.56% in the year ended Dec 31, 2024 (-8.21 pp) and 22.77% in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 23.26%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 12.61%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 8.85%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 23.71%
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 10.40%
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 17.54%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 20.70%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 3.96%
10 Genmab A 3.52 Bn -5.55 Bn 1.07 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 20.57%
Jun 30, 2024 33.88%
API Access

Genmab A Tax Rate API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-rate&ticker=GMAB&period=max&api_key=YOUR_API_KEY